This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David A. Newsome, MD
New Orleans, La

Arch Ophthalmol. 1992;110(11):1517.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—Dr Trempe seems unaware of a number of other clinical studies that have been published, at least in the popular press.¹ He exaggerates by calling 200 mg of zinc acetate "toxic." Not only did we not see evidence of toxic effects in our study, but also some physicians have given similar amounts to patients for many years without evidence of "toxicity."² Zinc sulfate is an emetic, and it is unlikely that one could ingest a truly toxic dose repeatedly. To have megaloblastic anemia, large amounts of zinc have to be ingested and retained by a patient.³

Although some of the subjects in the serum ceruloplasmin study⁴ later participated in our clinical trial, no subject was known to be taking "large amounts of zinc" when the serum samples that we studied were obtained. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?